BioTime, Inc. Share Price Nyse
Equities
US09066L1052
Biotechnology & Medical Research
Sales 2024 * | 12.22M 976M | Sales 2025 * | 5.87M 469M | Capitalization | 221M 17.64B |
---|---|---|---|---|---|
Net income 2024 * | -24M -1.92B | Net income 2025 * | -35M -2.8B | EV / Sales 2024 * | 18.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 37.6 x |
P/E ratio 2024 * |
-9
x | P/E ratio 2025 * |
-6.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.57% |
Latest transcript on BioTime, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 16/09/18 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 13/11/22 |
Chief Operating Officer | - | 31/12/09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 30/06/09 |
Brian Culley
CEO | Chief Executive Officer | 53 | 16/09/18 |
Director/Board Member | 66 | 10/04/14 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |